This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Burkitt's lymphoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Burkitt's lymphoma is a small, noncleaved cell lymphoma, described initially in Africa, where it is endemic in some parts, but occurring sporadically in nonendemic areas such as the United States.

In the African Burkitt's lymphoma there is a strong association with Epstein-Barr virus infection. Other associations include malarial infection and translocation involving chromosome 8 and 14.

Both the African and the non-African cases are found largely in children or young adults. In both forms, the disease rarely arises in the lymph nodes. In African cases, involvement of the maxilla or mandible is the common mode of presentation, whereas abdominal tumours - bowel, retroperitoneum, ovaries - are common in cases seen elsewhere. Leukaemic transformation of Burkitt's lymphoma is uncommon.

Management of Burkitt lymphoma

  • intensive immunochemotherapy should be offered to people with Burkitt lymphoma who are fit enough to tolerate it (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.